Bioventus (BVS) EPS (Diluted) Growth (3y) (2024 - 2026)
Powered by 
Analysis
Bioventus (BVS) EPS (Diluted) Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -12.16% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 24.50% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.81% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 50.83% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -6.12% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 33.46% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.07% |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn | 106.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 106.12% |
| Mar 28, 2026 | 26.41% |
| Dec 31, 2025 | 32.83% |
| Sep 27, 2025 | 26.51% |
| Jun 28, 2025 | 44.83% |
| Mar 29, 2025 | 40.98% |
| Dec 31, 2024 | -157.09% |
| Sep 28, 2024 | -18.22% |
| Jun 29, 2024 | -27.48% |
| Mar 30, 2024 | -29.50% |